For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Vaxcyte Inc (NASDAQ: PCVX) was $31.56 for the day, up 2.50% from the previous closing price of $30.79. In other words, the price has increased by $2.50 from its previous closing price. On the day, 1.85 million shares were traded. PCVX stock price reached its highest trading level at $32.0 during the session, while it also had its lowest trading level at $30.87.
Ratios:
Our analysis of PCVX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.11 and its Current Ratio is at 11.11. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135. On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.Mizuho initiated its Buy rating on December 07, 2023, with a $69 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 4097213696 and an Enterprise Value of 2521643008.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.04, which has changed by -0.7108566 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -5.25%, while the 200-Day Moving Average is calculated to be -44.28%.
Shares Statistics:
PCVX traded an average of 1.42M shares per day over the past three months and 1471710 shares per day over the past ten days. A total of 129.82M shares are outstanding, with a floating share count of 125.45M. Insiders hold about 3.36% of the company’s shares, while institutions hold 111.75% stake in the company. Shares short for PCVX as of 1755216000 were 11435242 with a Short Ratio of 8.03, compared to 1752537600 on 13618625. Therefore, it implies a Short% of Shares Outstanding of 11435242 and a Short% of Float of 9.86.
Earnings Estimates
The current assessment of Vaxcyte Inc (PCVX) involves the perspectives of 5.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$1.36, with high estimates of -$1.05 and low estimates of -$1.71.
Analysts are recommending an EPS of between -$4.34 and -$5.96 for the fiscal current year, implying an average EPS of -$5.1. EPS for the following year is -$5.97, with 5.0 analysts recommending between -$4.16 and -$7.28.
